Universe Pharmaceuticals INC
UPC
$5.94
-$1.15-16.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 79.82% | 80.68% | 81.11% | 65.38% | 49.27% |
| Total Depreciation and Amortization | -5.41% | 0.44% | 6.55% | 3.90% | 1.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.33% | -93.79% | -96.78% | -96.77% | -96.52% |
| Change in Net Operating Assets | -359.25% | -718.50% | -10.26% | 164.79% | 6,330.20% |
| Cash from Operations | -163.83% | -20.99% | 46.85% | 38.74% | 26.12% |
| Capital Expenditure | -74.91% | -43.59% | -8.54% | -51.76% | -147.30% |
| Sale of Property, Plant, and Equipment | 200.00% | 200.00% | 200.00% | 300.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -909.14% | -501.48% | 31.40% | -99.32% | -- |
| Cash from Investing | -374.11% | -200.08% | 5.37% | -62.62% | -283.45% |
| Total Debt Issued | -3.93% | -25.47% | -40.69% | -33.84% | -7.05% |
| Total Debt Repaid | -133.75% | -109.20% | -85.87% | -4.58% | 24.78% |
| Issuance of Common Stock | -100.00% | -76.92% | -40.00% | 120.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -115.40% | -96.29% | -71.36% | 47.77% | 1,605.76% |
| Foreign Exchange rate Adjustments | 211.74% | 199.63% | -289.78% | -242.85% | -99.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -151.32% | -124.94% | -83.09% | 111.26% | 1,038.51% |